Industry & Policy News

[Princeton University] Dr. Ilana Witten, a professor in the Princeton Neuroscience Institute, has been selected to receive a Director’s Pioneer Award from the National Institutes of Health.

[Nature] Scientists in Argentina are on edge as the country’s presidential election. If elected president, economist Javier Milei has pledged to eliminate government spending on research and shut down the environment and health ministries.

[MERCK] Merck announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as a monotherapy for the adjuvant treatment of adults with NSCLC who are at high risk of recurrence following complete resection and platinum-based chemotherapy.

[Washington University School of Medicine in St. Louis] Researchers at Washington University School of Medicine in St. Louis have received a prestigious Specialized Programs of Research Excellence grant from the National Cancer Institute (NCI) of the National Institutes of Health to support research and clinical trials aimed at improving therapies for pancreatic cancer.

[The Guardian] Some advanced forms of prostate cancer find it is able to evade treatment by using their immune system to resist the impact of drugs. Now scientists have discovered a way to stop it being able to do this, opening up the possibility of treatments for men left with little hope.

[Science Magazine] A pledge by the United Kingdom’s Conservative government to “kick woke ideology out of science” has stirred controversy among many scientists. In recent remarks, the top UK science official said the government aims to stop “the steady creep of political correctness” in research and will review the use of questions related to sex and gender in scientific studies.